Clinical Trial Detail

NCT ID NCT04161755
Title Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center

pancreatic ductal adenocarcinoma


Atezolizumab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin + RO7198457

Age Groups: senior adult

No variant requirements are available.